Purpose: To investigate the impact of implantoplasty (IP) with or without regenerative procedures on treatment outcomes of peri-implantitis.
Materials And Methods: Electronic and manual literature searches were conducted for clinical trials published up to October 2020 that evaluated clinical outcomes (at least 6-month follow-up) after peri-implantitis treatment involving IP. The implant survival rate and clinical parameters (eg, probing depth [PD], bleeding on probing [BOP], marginal bone loss [MBL], clinical attachment level [CAL], and mucosal recession [REC]) at baseline and follow-ups were extracted from original articles for qualitative analyses.